VERTEX PHARMACEUTICALS INC / MA 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 9, 2012
Insider Transaction Report
Form 4
Kelly Lisa
SVP, Human Resources
Transactions
- Exercise/Conversion
Stock Option
2012-05-07−3,813→ 0 totalExercise: $18.93Exp: 2018-02-06→ Common Stock (3,813 underlying) - Exercise/Conversion
Common Stock
2012-05-07$32.16/sh+3,813$122,626→ 60,981 total - Sale
Common Stock
2012-05-07$52.13/sh−7,187$374,658→ 37,552 total - Sale
Common Stock
2012-05-07$55.00/sh−16,242$893,310→ 44,739 total - Exercise/Conversion
Stock Option
2012-05-07−28,593→ 1,907 totalExercise: $32.16From: 2008-10-24Exp: 2018-07-23→ Common Stock (28,593 underlying) - Exercise/Conversion
Common Stock
2012-05-07$32.16/sh+28,593$919,551→ 57,168 total - Sale
Common Stock
2012-05-07$57.50/sh−14,297$822,078→ 23,255 total
Holdings
- 1,667(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
- [F2]Fully vested.